关键词: Stimforte TLR-4 and NOD-2 receptors Vero-V cells hepatitis C virus in vitro virus suppression interferon production

Mesh : Acetylmuramyl-Alanyl-Isoglutamine / pharmacology Adjuvants, Immunologic / administration & dosage pharmacology Animals Antiviral Agents / administration & dosage pharmacology Cell Survival / drug effects Chlorocebus aethiops Dose-Response Relationship, Drug Hepacivirus / drug effects physiology Hepatitis C / drug therapy immunology Interferons / metabolism Lipopolysaccharides / administration & dosage pharmacology Nod2 Signaling Adaptor Protein / metabolism Organic Chemicals / administration & dosage pharmacology Toll-Like Receptor 4 / metabolism Vero Cells Virus Replication / drug effects

来  源:   DOI:10.1134/S0012496620020076   PDF(Sci-hub)

Abstract:
Stimforte in a wide range of concentrations (15-225 µg/mL) totally inhibits the cytopathic activity of hepatitis C virus (HCV) in the Vero-V cell culture. Interferons (IFN) play the most important role in the suppression of infection when the drug is introduced into the culture before the infection. When Stimforte is introduced after the infection, the mechanism of action seems to be different. The activators of IFN production are mainly (or exclusively) the ligands of receptor complexes TLR-4 and NOD-2 contained in the drug. The action of these substances is probably synergistic, similar to the action of LPS and MDP in Vero-V cells.
摘要:
暂无翻译
公众号